MARKSANS

Marksans Pharma Share PriceMarksans Pharma

₹62.4
0.05 (0.08%)
As on 07 February, 2023 | 04:50 BSE: 524404 NSE: MARKSANS

Marksans Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Marksans Pharma

Start SIP

Marksans Pharma Share Price

  • Over 1 Month 7.03%
  • Over 3 Month 22.59%
  • Over 6 Month 24.92%
  • Over 1 Year 8.62%

Marksans Pharma Key Statistics

P/E Ratio 12.7
PEG Ratio -0.6
Market Cap Cr 2,828
Price to Book Ratio 2.1
EPS 2.3
Dividend 0.4
Relative Strength Index 48.11
Money Flow Index 55.72
MACD Signal 0.96
Average True Range 2.34

Marksans Pharma Investment Rating

  • Master Rating:
  • Marksans Pharma has an operating revenue of Rs. 1,667.01 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 17% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 19% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 76 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 106 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Marksans Pharma Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 170159176
Operating Expenses Qtr Cr 136148149
Operating Profit Qtr Cr 341227
Depreciation Qtr Cr 555
Interest Qtr Cr 111
Tax Qtr Cr 967
Net Profit Qtr Cr 401921

Marksans Pharma Technicals

EMA & SMA

Current Price
₹62.4
0.05 (0.08%)
  • Bullish Moving Average
  • ___
  • 7
  • Bearish Moving Average
  • ___
  • 9
  • 20 Day
  • 63.31
  • 50 Day
  • 61.19
  • 100 Day
  • 58.05
  • 200 Day
  • 55.92
  • 20 Day
  • 64.41
  • 50 Day
  • 61.95
  • 100 Day
  • 56.07
  • 200 Day
  • 52.42

Marksans Pharma Resistance and Support

PIVOT
₹62.69
Resistance
First Resistance 63.42
Second Resistance 64.49
Third Resistance 65.22
RSI 48.11
MFI 55.72
MACD Single Line 0.96
MACD 0.44
Support
First Resistance 61.62
Second Resistance 60.89
Third Resistance 59.82

Marksans Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,383,654 140,135,019 58.79
Week 2,050,868 94,401,463 46.03
1 Month 3,892,396 130,706,658 33.58
6 Month 2,214,640 82,628,201 37.31

Marksans Pharma Result Highlights

Marksans Pharma Synopsis

NSE-Medical-Diversified

Marksans Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 658.29 Cr. and Equity Capital is Rs. 40.93 Cr. for the Year ended 31/03/2022. Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364.
Market Cap 2,828
Sales 672
Shares in Float 25.38
No of funds 65
Yield 0.4
Book Value 3.26
U/D Vol ratio 1.9
LTDebt / Equity
Alpha 0.06
Beta 1.13

Marksans Pharma

Owner NameJan-23Dec-22Sep-22Jun-22
Promoters 43.8%49%48.6%
Mutual Funds 0.86%0.96%0.95%
Foreign Portfolio Investors 3.94%4.23%4.06%
Financial Institutions/ Banks
Individual Investors 35.19%39.69%39.76%
Others 16.21%6.12%6.63%

Marksans Pharma Management

Name Designation
Mr. Mark Saldanha Chairman & Managing Director
Mrs. Sandra Saldanha Whole Time Director
Mr. Varddhman V Jain Whole Time Director
Dr. Sunny Sharma Non Executive Director
Mr. Digant Mahesh Parikh Independent Director
Mr. Abhinna Sundar Mohanty Independent Director
Mr. Seetharama R Buddharaju Independent Director
Dr.(Mrs.) Meena Rani Surana Independent Director

Marksans Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Marksans Pharma Corporate Action

Date Purpose Remarks
2023-02-13 Quarterly Results
2023-01-20 Others Re.0.00 alia, to consider and approve allotment of fully paid-up Equity Shares having face value of Re. 1/- each against the convertible warrants on preferential basis.
2022-11-14 Quarterly Results
2022-08-13 Quarterly Results
2022-07-08 Buy Back of shares

Marksans Pharma MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 2870
Motilal Oswal S&P BSE Healthcare ETF 6

Marksans Pharma FAQs

What is Share Price of Marksans Pharma ?

Marksans Pharma share price is ₹62 As on 07 February, 2023 | 04:36

What is the Market Cap of Marksans Pharma ?

The Market Cap of Marksans Pharma is ₹2827.7 Cr As on 07 February, 2023 | 04:36

What is the P/E ratio of Marksans Pharma ?

The P/E ratio of Marksans Pharma is 12.7 As on 07 February, 2023 | 04:36

What is the PB ratio of Marksans Pharma ?

The PB ratio of Marksans Pharma is 2.1 As on 07 February, 2023 | 04:36

Q2FY23